Di (2-ethylhexyl) phthalate induces cardiac disorders in BALB/c mice.


Journal

Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 06 11 2018
accepted: 09 01 2019
pubmed: 20 1 2019
medline: 6 5 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

Because of the extensive use of phthalates for domestic, medical, and industrial applications, the evaluation of their toxic effects is of major concern to public health. The aim of the present study was to assess the propensity of di (2-ethylhexyl) phthalate (DEHP), one of the most used phthalates, to cause oxidative cardiac damage in mice. DEHP was administered intraperitoneally at doses of 5, 50, and 200 mg/kg body weight for 30 consecutive days in BALB/c mice. We assessed the effect of DEHP on cardiac injury using biochemical profile (such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), creatinine phosphokinase (CPK), total cholesterol (T-CHOL), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C)), parameters related to myocardiac oxidative stress, such as malondialdehyde (MDA) level, protein carbonyl (PC) concentration, and DNA fragmentation. In addition, we evaluated antioxidant status; enzymatic (catalase (CAT) and superoxide dismutase (SOD) activities) and non-enzymatic (protein-bound sulfhydryl concentration (PSH)) antioxidants. Acetylcholinesterase (AChE) activity and histopathological changes were also assessed in heart mice treated with DEHP. Our results showed that DEHP induced an elevation of serum marker enzymes and perturbated the lipid profile. In addition, this phthalate increased lipid peroxidation, protein carbonyl levels, and DNA fragmentation in the heart in a dose-dependent manner. Antioxidant status was also perturbated by the increase of the CAT and SOD activities and the decrease of the protein-bound sulfhydryl concentration. AChE activity was also inhibited in the heart following the treatment with DEHP. These biochemical alterations were also confirmed by histopathological changes. Increased free radical production at various doses of DEHP would result in impairment of the redox status leading to an enhanced dose-dependent cardiotoxicity.

Identifiants

pubmed: 30659488
doi: 10.1007/s11356-019-04219-w
pii: 10.1007/s11356-019-04219-w
doi:

Substances chimiques

Antioxidants 0
Hazardous Substances 0
Phthalic Acids 0
Malondialdehyde 4Y8F71G49Q
phthalic acid 6O7F7IX66E
Diethylhexyl Phthalate C42K0PH13C
Catalase EC 1.11.1.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7540-7549

Références

Medicina (Kaunas). 2014;50(6):329-33
pubmed: 25541265
Meat Sci. 2004 Feb;66(2):467-73
pubmed: 22064150
Toxicology. 2011 Jan 11;279(1-3):54-64
pubmed: 20920545
Cytotechnology. 2018 Feb;70(1):119-128
pubmed: 28689280
Mutat Res. 1985 Jan-Feb;148(1-2):25-34
pubmed: 3881660
Toxicol Appl Pharmacol. 1978 Jul;45(1):1-27
pubmed: 358497
Bratisl Lek Listy. 2017;118(8):460-466
pubmed: 29050483
Cell Physiol Biochem. 2014;34(5):1614-25
pubmed: 25402826
PLoS One. 2016 Apr 04;11(4):e0152925
pubmed: 27043143
Sci Total Environ. 2014 Feb 1;470-471:726-32
pubmed: 24184549
Toxicol Mech Methods. 2017 Sep;27(7):551-559
pubmed: 28532275
Lancet. 2001 Sep 29;358(9287):1064-5
pubmed: 11589940
Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57
pubmed: 10388618
Food Chem Toxicol. 2017 May;103:157-167
pubmed: 28284729
Cardiovasc Res. 2004 Apr 1;62(1):112-21
pubmed: 15023558
Chem Biol Interact. 2006 Feb 1;159(2):81-9
pubmed: 16256967
Reprod Toxicol. 2002 Sep-Oct;16(5):529-653
pubmed: 12406494
Clin Biochem. 2000 Mar;33(2):103-6
pubmed: 10751587
Toxicol Appl Pharmacol. 2009 Apr 1;236(1):25-38
pubmed: 19344669
Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G1-7
pubmed: 16500922
Mutat Res. 1993 Dec;290(2):183-92
pubmed: 7694109
PLoS One. 2010 Jan 13;5(1):e8673
pubmed: 20084273
Anal Biochem. 1979 Jun;95(2):351-8
pubmed: 36810
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):689-95
pubmed: 16410455
Biol Trace Elem Res. 2016 Feb;169(2):261-70
pubmed: 26150403
Mol Genet Metab Rep. 2015 May 22;4:1-5
pubmed: 26937402
J Lipid Res. 2011 Mar;52(3):566-71
pubmed: 21224290
Gan. 1982 Oct;73(5):681-3
pubmed: 6762317
Environ Health Perspect. 1996 May;104 Suppl 3:465-9
pubmed: 8781365
Anal Biochem. 1968 Oct 24;25(1):192-205
pubmed: 4973948
Toxicol Appl Pharmacol. 2013 Jan 1;266(1):95-100
pubmed: 23142467
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2181-90
pubmed: 21949114
Cardiovasc Toxicol. 2014 Dec;14(4):339-57
pubmed: 24811950
Endocr Rev. 2009 Jun;30(4):293-342
pubmed: 19502515
Am J Ind Med. 2001 Jan;39(1):100-11
pubmed: 11148020
Environ Pollut. 2016 Jan;208(Pt B):416-25
pubmed: 26549752
Eur J Biochem. 1974 Sep 16;47(3):469-74
pubmed: 4215654
Food Chem Toxicol. 2010 Jul;48(7):1969-72
pubmed: 20451575
Environ Pollut. 2017 Jul;226:435-443
pubmed: 28413083
Science. 1996 Jul 5;273(5271):59-63
pubmed: 8658196
Environ Toxicol Pharmacol. 2015 May;39(3):1099-106
pubmed: 25899473
Curr Med Res Opin. 2003;19(2):89-94
pubmed: 12755140
Arch Microbiol. 2009 May;191(5):473-6
pubmed: 19330318
Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H1044-H1053
pubmed: 28842438
Chemosphere. 2018 Jan;190:375-382
pubmed: 29020644
Environ Health Perspect. 2005 Sep;113(9):1222-5
pubmed: 16140631

Auteurs

Ines Amara (I)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.

Rim Timoumi (R)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.

Emna Annabi (E)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.

Fadwa Neffati (F)

Laboratory of Biochemistry-Toxicology, University of Monastir, Monastir University Hospital, Monastir, Tunisia.

Mohamed Fadhel Najjar (MF)

Laboratory of Biochemistry-Toxicology, University of Monastir, Monastir University Hospital, Monastir, Tunisia.

Chayma Bouaziz (C)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia.

Salwa Abid-Essefi (S)

Faculty of Dental Medicine, Laboratory for Research on Biologically Compatible Compounds, University of Monastir, LR01SE1, Rue Avicenne, 5000, Monastir, Tunisia. salwaabid@yahoo.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH